Why the study?
The association between the glycaemia risk index, a novel continuous glucose monitoring metric, and atherosclerosis in patients with type 2 diabetes had not been determined.
Does the glycaemia risk index (GRI) associate with indices of atherosclerosis in patients with type 2 diabetes?
Does the glycaemia risk index (GRI) associate with indices of atherosclerosis in patients with type 2 diabetes?
Answers are grounded in this paper and cite their sources.
The glycaemia risk index (GRI) is significantly associated with surrogate markers of atherosclerosis (GSM and baPWV) in patients with type 2 diabetes, suggesting its potential utility for cardiovascular risk assessment.
AIMS: This study determined the association of the glycaemia risk index (GRI), a novel comprehensive metric derived from continuous glucose monitoring (CGM), and atherosclerosis in patients with type 2 diabetes (T2DM). METHODS: We evaluated the relationship between GRI and intima-media thickness (IMT), gray-scale median (GSM), tissue characteristics of the carotid artery wall, and brachial-ankle pulse wave velocity (baPWV), using baseline data from a multicenter prospective cohort study of 1000 Japanese patients with T2DM free of cardiovascular disease (CVD). A higher GRI was associated with a longer duration of diabetes, a higher HbA1c level, a mean glucose level, and baPWV, and lower mean GSM. No association was noted between GRI and mean IMT. GRI was significantly associated with mean GSM (regression coefficient, β = -0.1277; 95% confidence interval: CI: -0.2165 to -0.0390, p = 0.005) and baPWV (regression coefficient, β = -3.1568; 95% CI: 1.5058 to 4.8079, p < 0.001) after adjustment for various cardiovascular risk factors. CONCLUSIONS: GRI is a potentially useful predictor of atherosclerosis in patients with T2DM. Our findings suggest that GRI, a marker of the risk of hypoglycaemia and hyperglycaemia, may serve as a clinically useful tool for the assessment of the risk of CVD in patients with T2DM, independent of the classical cardiovascular risk factors.
No takes yet. Share an insight, caveat, or question.
Torimoto et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: